Breast cancer still top disease area for clinical studies
Drug Discovery World
FEBRUARY 10, 2023
Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, despite a drop in activity, according to analysis from analytics company Phesi. However, the reduction in breast cancer trials is unexpected, with 113 fewer recruiting trials in 2022 compared with 2021. Download the full report.
Let's personalize your content